ES2160115T3 - Anticuerpo de recombinacion dirigido contra el herpes-virus felino de tipo 1 y fragmento genico codante para dicho anticuerpo. - Google Patents

Anticuerpo de recombinacion dirigido contra el herpes-virus felino de tipo 1 y fragmento genico codante para dicho anticuerpo.

Info

Publication number
ES2160115T3
ES2160115T3 ES94901002T ES94901002T ES2160115T3 ES 2160115 T3 ES2160115 T3 ES 2160115T3 ES 94901002 T ES94901002 T ES 94901002T ES 94901002 T ES94901002 T ES 94901002T ES 2160115 T3 ES2160115 T3 ES 2160115T3
Authority
ES
Spain
Prior art keywords
antibody
fhv
felino
codant
genuine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94901002T
Other languages
English (en)
Inventor
Kazuhiko Kimachi
Hiroaki Maeda
Kiyoto Nishiyama
Sachio Tokiyoshi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemo Sero Therapeutic Research Institute Kaketsuken
Original Assignee
Chemo Sero Therapeutic Research Institute Kaketsuken
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeutic Research Institute Kaketsuken filed Critical Chemo Sero Therapeutic Research Institute Kaketsuken
Application granted granted Critical
Publication of ES2160115T3 publication Critical patent/ES2160115T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/085—Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/80—Antibody or fragment thereof whose amino acid sequence is disclosed in whole or in part
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/801—Drug, bio-affecting and body treating compositions involving antibody or fragment thereof produced by recombinant dna technology
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/809—Drug, bio-affecting and body treating compositions involving immunoglobulin or antibody fragment, e.g. fab', fv, fc, heavy chain or light chain

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

UN ANTICUERPO RECOMBINANTE DE VIRUS-HERPES-1 ANTI-FELINO QUE ES EFICAZ EN EL TRATAMIENTO, PREVENCION Y DIAGNOSTICO DE INFECCION POR VIRUS-HERPES-1 FELINO (FHV-1), Y UN FRAGMENTO GENETICO UTIL PARA LA PREPARACION DEL ANTICUERPO. UN CODIGO DE FRAGMENTO GENETICO PARA LA ZONA DEL ANTICUERPO V, QUE TIENE UNA AVIDEZ ESPECIFICA DE FHV-1 DE UN ANTICUERPO MONOCLONAL DE RATON QUE TIENE UNA EXCELENTE ACTIVIDAD NEUTRALIZADORA DE FHV-1, SE OBTIENE CONSTRUYENDO CELULAS QUE PRODUCEN EL ANTICUERPO. UN ANTICUERPO RECOMBINANTE ANTI-FHV-1 QUIMERICO SE PREPARA A PARTIR DEL FRAGMENTO GENETICO MENCIONADO Y DE OTRO CODIGO DE FRAGMENTO GENETICO PARA UNA ZONA C DE ANTICUERPO FELINO.
ES94901002T 1992-11-28 1993-11-25 Anticuerpo de recombinacion dirigido contra el herpes-virus felino de tipo 1 y fragmento genico codante para dicho anticuerpo. Expired - Lifetime ES2160115T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP34125592A JP3919830B2 (ja) 1992-11-28 1992-11-28 抗ネコヘルペスウイルス−１組換え抗体および該抗体をコードする遺伝子断片

Publications (1)

Publication Number Publication Date
ES2160115T3 true ES2160115T3 (es) 2001-11-01

Family

ID=18344623

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94901002T Expired - Lifetime ES2160115T3 (es) 1992-11-28 1993-11-25 Anticuerpo de recombinacion dirigido contra el herpes-virus felino de tipo 1 y fragmento genico codante para dicho anticuerpo.

Country Status (9)

Country Link
US (1) US5760185A (es)
EP (1) EP0671472B1 (es)
JP (1) JP3919830B2 (es)
AT (1) ATE199745T1 (es)
AU (1) AU674043B2 (es)
CA (1) CA2150346C (es)
DE (1) DE69330031T2 (es)
ES (1) ES2160115T3 (es)
WO (1) WO1994012661A1 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4347694B2 (ja) * 2001-10-16 2009-10-21 レイベン バイオテクノロジーズ，インコーポレイティド 癌関連抗原ｃｄ４６に結合する抗体およびその使用方法
BRPI0214188B8 (pt) 2001-11-08 2021-05-25 Beijing Wantai Biological Pharmacy Entpr Co Ltd anticorpo ou fragmento do mesmo, molécula de ácido nucléico, uso do anticorpo monoclonal ou fragmento do mesmo, kit de diagnóstico, composição farmacêutica, vetor de expressão recombinante, célula hospedeira transformada com o vetor de expressão recombinante e método para detectar o antígeno do vírus da hepatite e ou o anticorpo contra o vírus da hepatite e em uma amostra
CA2505633A1 (en) * 2002-11-13 2004-05-27 Raven Biotechnologies, Inc. Antigen pipa and antibodies that bind thereto
AU2006261127B2 (en) 2005-06-17 2012-03-15 Merck Sharp & Dohme Corp. ILT3 binding molecules and uses therefor
WO2008094176A2 (en) * 2006-06-19 2008-08-07 Tolerx, Inc. Ilt3 binding molecules and uses therefor
AU2007320024B2 (en) 2006-10-02 2012-11-08 E. R. Squibb & Sons, L.L.C. Human antibodies that bind CXCR4 and uses thereof
SG177168A1 (en) 2006-12-01 2012-01-30 Medarex Inc Human antibodies that bind cd22 and uses thereof
CL2007003622A1 (es) 2006-12-13 2009-08-07 Medarex Inc Anticuerpo monoclonal humano anti-cd19; composicion que lo comprende; y metodo de inhibicion del crecimiento de celulas tumorales.
NZ578354A (en) 2006-12-14 2012-01-12 Medarex Inc Antibody-partner molecule conjugates that bind cd70 and uses thereof
JP5648912B2 (ja) 2008-02-27 2015-01-07 国立大学法人北海道大学 動物細胞を用いて外来遺伝子由来タンパク質を大量に生産するための発現ベクター、およびその利用
AR072999A1 (es) 2008-08-11 2010-10-06 Medarex Inc Anticuerpos humanos que se unen al gen 3 de activacion linfocitaria (lag-3) y los usos de estos
PT2385115E (pt) 2008-12-22 2015-11-24 Univ Hokkaido Nat Univ Corp Vetor de expressão para produção de proteína derivada de gene exógeno em grandes quantidades usando células animais e seu uso
JP2013520999A (ja) * 2010-03-04 2013-06-10 ベット・セラピューティクス・インコーポレイテッド Ｃｄ５２に対するモノクローナル抗体
US9616120B2 (en) 2010-03-04 2017-04-11 Vet Therapeutics, Inc. Monoclonal antibodies directed to CD20
EP2542262A4 (en) * 2010-03-04 2014-02-26 Vet Therapeutics Inc MONOCLONAL ANTIBODIES DIRECTED AGAINST CD20
US9546219B2 (en) 2012-02-08 2017-01-17 North Carolina State University Treatment of allergic diseases with recombinant antibodies
UY34887A (es) 2012-07-02 2013-12-31 Bristol Myers Squibb Company Una Corporacion Del Estado De Delaware Optimización de anticuerpos que se fijan al gen de activación de linfocitos 3 (lag-3) y sus usos
CA2944989A1 (en) * 2013-04-08 2014-10-16 Cytodyn Inc. Felinized antibodies and methods of treating retroviral infections in felines
CA3041717A1 (en) 2016-11-09 2018-05-17 North Carolina State University Treatment of allergic diseases with chimeric protein
US10093731B2 (en) 2017-02-24 2018-10-09 Kindred Biosciences, Inc. Anti-IL31 antibodies for veterinary use
AU2019273200A1 (en) 2018-05-24 2020-12-03 Fuso Pharmaceutical Industries,Ltd. Novel vector and use thereof
TWI754157B (zh) 2018-07-25 2022-02-01 大陸商信達生物製藥（蘇州）有限公司 抗ｔｉｇｉｔ抗體及其用途
CN109762067B (zh) 2019-01-17 2020-02-28 北京天广实生物技术股份有限公司 结合人Claudin 18.2的抗体及其用途
EP4110816A1 (en) 2020-02-27 2023-01-04 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Antibodies binding il4r and uses thereof
KR20230010691A (ko) 2020-05-12 2023-01-19 치아타이 티안큉 파마수티컬 그룹 주식회사 St2 항원 결합 단백질
CN116284350B (zh) * 2023-05-06 2023-08-04 泰州博莱得利生物科技有限公司 一种猫疱疹病毒单克隆抗体及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
JPH01309785A (ja) 1988-06-06 1989-12-14 Babcock Hitachi Kk ミドルパルスｔｉｇ溶接装置
JP2811095B2 (ja) * 1989-09-30 1998-10-15 財団法人化学及血清療法研究所 ネコ免疫グロブリンκ鎖の定常領域をコードする遺伝子断片およびマウス×ネコキメラ抗体
JP2811086B2 (ja) * 1989-08-10 1998-10-15 財団法人化学及血清療法研究所 ネコ×マウスヘテロハイブリドーマおよびネコ免疫グロブリンλ鎖の定常領域をコードする遺伝子断片
JP2811102B2 (ja) * 1989-12-28 1998-10-15 財団法人化学及血清療法研究所 ネコ免疫グロブリンγ鎖の定常領域をコードする遺伝子断片およびマウス×ネコキメラ抗体
AU632843B2 (en) * 1989-08-10 1993-01-14 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Cat-mouse heterohybridoma and gene fragment coding for constant region of feline immunoglobulin
JPH03123486A (ja) * 1989-10-06 1991-05-27 Hitachi Ltd 膜蛋白質の遺伝子工学的生産方法

Also Published As

Publication number Publication date
AU5596194A (en) 1994-06-22
DE69330031D1 (de) 2001-04-19
EP0671472A4 (en) 1997-11-19
JPH06217786A (ja) 1994-08-09
CA2150346C (en) 2005-08-09
WO1994012661A1 (en) 1994-06-09
DE69330031T2 (de) 2001-07-19
EP0671472B1 (en) 2001-03-14
US5760185A (en) 1998-06-02
AU674043B2 (en) 1996-12-05
ATE199745T1 (de) 2001-03-15
CA2150346A1 (en) 1994-06-09
JP3919830B2 (ja) 2007-05-30
EP0671472A1 (en) 1995-09-13

Similar Documents

Publication Publication Date Title
ES2160115T3 (es) Anticuerpo de recombinacion dirigido contra el herpes-virus felino de tipo 1 y fragmento genico codante para dicho anticuerpo.
TW279832B (es)
CA2114015A1 (en) Recombinant antibodies for human therapy
IL135578A0 (en) Compositions and methods for treating lysosomal storage disease
PL343322A1 (en) Humanized antibody against human tissue factor (tf) and process for constructing humanized antibody
DE3582258D1 (de) Bildverbesserungsverfahren durch rasterabtastung.
CA2139507A1 (en) Vaccines against aujeszky's disease and other animal diseases containing pseudorabies virus mutants
HUT68162A (en) Protein having a cytokinin-type activity, recombinant dna coding for this protein transformed cells and micro-organisms
DE69328595T2 (de) Bildverbesserung
ZA967411B (en) Blue copper oxidase mutants with enhanced activity
NZ319160A (en) An adhesin gene from helicobacter pylori, polypeptide coded thereby, vectors, cells, antibodies and immunogenic compositions
EP0184575A3 (en) Transformed yeasts producing lysozyme, plasmids used for this transformation, and uses thereof
MY116010A (en) Termiticide and method for termite control using the same
AU2085195A (en) Gene coding for igg-fc-binding protein
HK1048830A1 (en) Trap vector and gene trapping method by using the same
AU2898995A (en) Dna coding for phosphoenolpyruvate carboxykinase, recombinant vector containing the same, and transgenic plant
Mwenya et al. Improving animal traction technology
EP1947117A3 (en) Glycoprotein hormone superagonists
HUT63636A (en) Process for producing hybrid calcitonin
DE69116803D1 (de) Peroxidase-Gen von mikrobischem Ursprung
AU3391193A (en) Anti-feline calicivirus recombinant antibody and gene fragment encoding the same
ATE217909T1 (de) Verwendung und herstellung eines metastaseninhibitors bzw. eines zelladhäsionsinhibitors enthaltend einen antikörper
EP0321268A3 (en) Method for producing the bani restriction endonuclease and methylase
BR8301534A (pt) Processo para a preparacao de esteres de acido n, n - dimetil - 0 - pirimidin - 4 - il - carbamico substituidos, processo para a preparacao de hidroxi - pirimidinas, composicoes praguicidas, processo para o combate de pragas e para a preparacao de composicoes
GB9600660D0 (en) Protein

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 671472

Country of ref document: ES